Clinical Trial Update: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers [EARLY_Phase 1]

View source ↗

Summary

Early-phase study evaluating pembrolizumab in gynecologic cancers; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Gynecologic Neoplasms
• Peritoneal Cancer
• Uterine Endometrial Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: AA Secord | Conditions: Gynecologic Neoplasms, Epithelial Ovarian Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-07-09